Status:
RECRUITING
Effect of CKC and WS Exercises on Postural Stability in Unilateral Post Mastectomy Lymphedema
Lead Sponsor:
Cairo University
Conditions:
Postmastectomy Lymphedema
Eligibility:
FEMALE
40-60 years
Phase:
NA
Brief Summary
Post-mastectomy lymphedema is one of the most common chronic complications that significantly impacts patients' quality of life following breast cancer surgery. postural stability is maintained throug...
Detailed Description
Sixty patients who have unilateral post mastectomy lymphedema will participate in this study. Their ages will range from 40 to 60 years. The patients will be subdivided randomly into four equal groups...
Eligibility Criteria
Inclusion
- Women who had a history of BCRS with upper limb lymphedema. • Age range of 40-60 years.
- • The body mass index (BMI) is less than 30 Kg/m2.
- • Consciousness and ability to communicate orally or in writing.
- • Treatment by unilateral mastectomy with lymph node dissection.
- • No obvious abnormal spine morphology or postural abnormalities visible to the naked eye.
- • All participants had moderate lymphedema according to the lymphedema severity assessment.
Exclusion
- Patients with metastases. • Differences between lower limb length.
- • Having acute or chronic vestibular, neurological, and orthopedic diseases.
- • Surgery related to spine causing limitation of motion.
- • Women with psychiatric disorders, reconstructive surgery.
- • Bilateral mastectomy. Diagnosis with a neurological, skeletal, or rheumatic disorder or other disease that seriously affects body posture.
- • History of bodily injury such as a spinal, shoulder, or neck injury, resulting in permanent alteration of the normal body posture prior to the unilateral mastectomy.
- • Failure to complete follow-up for any reason over the course of the study.
- • Peripheral polyneuropathy, cognitive dysfunction.
- • Patients taking medication that affects body balance.
- • Severe arthritis or orthopedic conditions in their lower extremity
- • Poor conditioning, acute pain in any reason,
- • Neurological disorders including visual problems.
Key Trial Info
Start Date :
April 30 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2026
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06977620
Start Date
April 30 2025
End Date
May 1 2026
Last Update
May 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo University
Giza, Egypt